Tag: HTI-501

New data on HTI-501 tolerability for cellulite

Jul 3, 2013 | 0 |

Halozyme Therapeutics, Inc. has announced interim results from a proof of concept Phase I/II clinical trial evaluating the activity and...

Start date: June 8, 2022 - End date: June 11, 2022

Time: 12:00 am - 12:00 am

Location: Las Vegas, USA

Start date: June 17, 2022 - End date: June 18, 2022

Time: 12:00 am - 12:00 am

Location: London, UK

Start date: July 7, 2022 - End date: July 10, 2022

Time: 12:00 am - 12:00 am

Start date: November 4, 2022 - End date: November 5, 2022

Time: 12:00 am - 12:00 am

Location: Monte Carlo, Monaco

Start date: November 5, 2022 - End date: November 6, 2022

Time: 12:00 am - 12:00 am

Location: Tokyo, Japan